The presence of TERT mutations is also important for glioma prognosis, since gliomas (in particular LGGs) with concomitant IDH and TERT mutations are associated with better prognosis, while patients with IDH-wildtype and TERT mutated GBMs have poorer prognoses. The gene discussed is IDH2; the disease is central nervous system cancer.